Literature DB >> 9563464

Frequent abnormalities of the putative tumor suppressor gene FHIT at 3p14.2 in pancreatic carcinoma cell lines.

B Simon1, D Bartsch, P Barth, N Prasnikar, K Münch, A Blum, R Arnold, B Göke.   

Abstract

The FHIT gene is localized on chromosome 3p14, a region including a tumor cell-specific, commonly deleted region. To determine the role of the FHIT gene in pancreatic carcinogenesis, 14 pancreatic carcinoma cell lines were analyzed by reverse transcription-PCR and exon-specific PCR amplification of genomic DNA. The full-length FHIT transcript was lost in 70% of the pancreatic carcinoma cell lines analyzed, while 66% also revealed intragenic homozygous deletions of exons 3, 4, and 5. Truncated FHIT transcripts lacking a variable number of exons most likely represented alternative splicing products. Fhit protein expression was dependent on a full-length FHIT transcript. The results suggest that the FHIT gene may be a target tumor suppressor gene involved in pancreatic carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9563464

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Fhit down-regulation is an early event in pancreatic carcinogenesis.

Authors:  Matteo Fassan; Borislav Rusev; Vincenzo Corbo; Pierluigi Gasparini; Claudio Luchini; Caterina Vicentini; Andrea Mafficini; Salvatore Paiella; Roberto Salvia; Ivana Cataldo; Aldo Scarpa; Kay Huebner
Journal:  Virchows Arch       Date:  2017-03-13       Impact factor: 4.064

2.  Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype.

Authors:  H Ouyang; Lj Mou; C Luk; N Liu; J Karaskova; J Squire; M S Tsao
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

Review 3.  DNA copy number losses in human neoplasms.

Authors:  S Knuutila; Y Aalto; K Autio; A M Björkqvist; W El-Rifai; S Hemmer; T Huhta; E Kettunen; S Kiuru-Kuhlefelt; M L Larramendy; T Lushnikova; O Monni; H Pere; J Tapper; M Tarkkanen; A Varis; V M Wasenius; M Wolf; Y Zhu
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

4.  FHIT protein expression and its relation to apoptosis, tumor histologic grade and prognosis in colorectal adenocarcinoma: an immunohistochemical and image analysis study.

Authors:  Hussam H Mady; Mona F Melhem
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

5.  Coordinate loss of fragile gene expression in pancreatobiliary cancers: correlations among markers and clinical features.

Authors:  Mark Bloomston; Jeffrey Kneile; Matthew Butterfield; Mary Dillhoff; Peter Muscarella; E Christopher Ellison; W Scott Melvin; Carlo M Croce; Flavia Pichiorri; Kay Huebner; Wendy L Frankel
Journal:  Ann Surg Oncol       Date:  2009-05-12       Impact factor: 5.344

6.  Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer.

Authors:  I Garrido-Laguna; A C Tan; M Uson; M Angenendt; W W Ma; M C Villaroel; M Zhao; N V Rajeshkumar; A Jimeno; R Donehower; C Iacobuzio-Donahue; M Barrett; M A Rudek; B Rubio-Viqueira; D Laheru; M Hidalgo
Journal:  Br J Cancer       Date:  2010-07-27       Impact factor: 7.640

7.  HIT family genes: FHIT but not PKCI-1/HINT produces altered transcripts in colorectal cancer.

Authors:  J Elnatan; D Murphy; H S Goh; D R Smith
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

8.  Loss of Fhit expression in non-small-cell lung cancer: correlation with molecular genetic abnormalities and clinicopathological features.

Authors:  J Geradts; K M Fong; P V Zimmerman; J D Minna
Journal:  Br J Cancer       Date:  2000-03       Impact factor: 7.640

9.  FHIT overexpression in HepG2 hepatoma cells affects growth and cyclin D1 expression in vitro.

Authors:  Jiayun Ge; Simin Shen; Xiaowen Zhang; Kun Wang; Bo Liu; Deyun Sun; Lin Wang
Journal:  Exp Ther Med       Date:  2013-12-04       Impact factor: 2.447

10.  p8 inhibits the growth of human pancreatic cancer cells and its expression is induced through pathways involved in growth inhibition and repressed by factors promoting cell growth.

Authors:  Cédric Malicet; Nathalie Lesavre; Sophie Vasseur; Juan L Iovanna
Journal:  Mol Cancer       Date:  2003-11-05       Impact factor: 27.401

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.